Advertisement
Advertisement
U.S. markets open in 5 hours 4 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Oxford Biomedica plc (OXB.L)

LSE - LSE Delayed Price. Currency in GBp (0.01 GBP)
Add to watchlist
502.68+0.68 (+0.14%)
As of 08:56AM BST. Market open.
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in GBp

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 8/6/2022
Current
Market Cap (intraday)
482.33M
Enterprise Value
382.65M
Trailing P/E
22.79
Forward P/E
N/A
PEG Ratio (5 yr expected)
N/A
Price/Sales (ttm)
2.96
Price/Book (mrq)
2.60
Enterprise Value/Revenue
2.68
Enterprise Value/EBITDA
11.52

Trading Information

Stock Price History

Beta (5Y Monthly) 0.96
52-Week Change 3-63.03%
S&P500 52-Week Change 3-6.48%
52 Week High 31,678.00
52 Week Low 3414.00
50-Day Moving Average 3475.39
200-Day Moving Average 3810.05

Share Statistics

Avg Vol (3 month) 3165.37k
Avg Vol (10 day) 384.06k
Shares Outstanding 596.08M
Implied Shares Outstanding 6N/A
Float 862.68M
% Held by Insiders 19.06%
% Held by Institutions 167.00%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:50
Last Split Date 3May 30, 2018

Financial Highlights

Currency in GBP.

Fiscal Year

Fiscal Year Ends Dec 31, 2021
Most Recent Quarter (mrq)Dec 31, 2021

Profitability

Profit Margin 13.31%
Operating Margin (ttm)14.66%

Management Effectiveness

Return on Assets (ttm)6.21%
Return on Equity (ttm)12.67%

Income Statement

Revenue (ttm)142.8M
Revenue Per Share (ttm)1.71
Quarterly Revenue Growth (yoy)14.50%
Gross Profit (ttm)82.64M
EBITDA 31.46M
Net Income Avi to Common (ttm)19.01M
Diluted EPS (ttm)0.22
Quarterly Earnings Growth (yoy)117.10%

Balance Sheet

Total Cash (mrq)109.02M
Total Cash Per Share (mrq)1.26
Total Debt (mrq)9.34M
Total Debt/Equity (mrq)4.99
Current Ratio (mrq)4.92
Book Value Per Share (mrq)2.17

Cash Flow Statement

Operating Cash Flow (ttm)25.45M
Levered Free Cash Flow (ttm)10.13M
Advertisement
Advertisement